Literature DB >> 7886951

A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.

M D Moody1, S C Pettit, W Shao, L Everitt, D D Loeb, C A Hutchison, R Swanstrom.   

Abstract

Substitution of glycine with glutamic acid at position 48 of the human immunodeficiency virus protease resulted in an enzyme with reduced activity on one of the protease processing sites in the viral Pol polyprotein precursor. Cleavage at this site was restored by a second-site substitution in the substrate replacing an aspartic acid with either glycine or asparagine. These results suggest that the glutamic acid side chain in the mutant protease has an unfavorable charge-charge interaction with this position in the substrate. Cleavage of a processing site in the viral Gag polyprotein precursor with the mutant enzyme was enhanced, and this enhancement was dependent on the presence of an arginine residue in the substrate, again suggesting a charge-charge interaction. The potential for such interactions was confirmed using molecular modeling. The effect of the position 48 substitution was attributed to a 10-fold increase in Km for the processing site in Pol. These results indicate that the addition of a side chain at position 48 can alter the specificity of the HIV-1 protease to substrate in a sequence specific manner and that compensatory changes can be made in the substrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7886951     DOI: 10.1006/viro.1995.1107

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease.

Authors:  Oscar Alvizo; Seema Mittal; Stephen L Mayo; Celia A Schiffer
Journal:  Protein Sci       Date:  2012-06-05       Impact factor: 6.725

2.  Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors.

Authors:  L Doyon; G Croteau; D Thibeault; F Poulin; L Pilote; D Lamarre
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

3.  Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants.

Authors:  W Shao; L Everitt; M Manchester; D D Loeb; C A Hutchison; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Characterization of peptide substrates and viral enzyme that affect the cleavage site specificity of the human spumaretrovirus proteinase.

Authors:  K I Pfrepper; J Reed; H R Rackwitz; M Schnölzer; R M Flügel
Journal:  Virus Genes       Date:  2001-01       Impact factor: 2.332

5.  Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism.

Authors:  Steven C Pettit; Lorraine E Everitt; Sumana Choudhury; Ben M Dunn; Andrew H Kaplan
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.

Authors:  Steve C Pettit; Jeffrey N Lindquist; Andrew H Kaplan; Ronald Swanstrom
Journal:  Retrovirology       Date:  2005-11-01       Impact factor: 4.602

7.  Defective hydrophobic sliding mechanism and active site expansion in HIV-1 protease drug resistant variant Gly48Thr/Leu89Met: mechanisms for the loss of saquinavir binding potency.

Authors:  Nathan E Goldfarb; Meray Ohanessian; Shyamasri Biswas; T Dwight McGee; Brian P Mahon; David A Ostrov; Jose Garcia; Yan Tang; Robert McKenna; Adrian Roitberg; Ben M Dunn
Journal:  Biochemistry       Date:  2015-01-07       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.